Clover Health Investments (CLOV) Long-Term Investments (2020 - 2026)

Clover Health Investments has reported Long-Term Investments for 7 years, with the latest figure at $241.3 million in Q1 2026.

• For the quarter ending Q1 2026, Long-Term Investments rose 1593.97% year-over-year to $241.3 million; the trailing twelve-month figure through Mar 2026 stood at $241.3 million (up 1593.97% YoY), and the FY2025 full-year result was $224.0 million, up 11.07% from the prior year.
• Long-Term Investments for Q1 2026 stood at $241.3 million, up from $224.0 million in the prior quarter.
• The five-year high for Long-Term Investments was $310.5 million in Q3 2023, with the low at $742000.0 in Q4 2022.
• Historically, Long-Term Investments has averaged $133.8 million across 5 years, with a median of $158.7 million in 2022.
• Annual changes were most pronounced in 2022 — Long-Term Investments plunged 99.63% — and 2023, when it soared 16100.54%.
• Clover Health Investments' Long-Term Investments stood at $742000.0 in 2022, then soared by 16100.54% to $120.2 million in 2023, then soared by 67.81% to $201.7 million in 2024, then increased by 11.07% to $224.0 million in 2025, then grew by 7.72% to $241.3 million in 2026.
• The last three Long-Term Investments figures came in at $241.3 million (Q1 2026), $224.0 million (Q4 2025), and $180.7 million (Q3 2025), per Business Quant data.